Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia
- 23 September 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 121 (2), 431-437
- https://doi.org/10.1007/s10549-009-0534-7
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Time-Varying Effects of Prognostic Factors Associated With Disease-Free Survival in Breast CancerAmerican Journal of Epidemiology, 2009
- Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast CancerClinical Cancer Research, 2008
- Assessment of the Accuracy of the Gail Model in Women With Atypical HyperplasiaJournal of Clinical Oncology, 2008
- Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityBritish Journal of Cancer, 2008
- Generalisability of survival estimates for patients with breast cancer – A comparison across two population-based seriesEuropean Journal of Cancer, 2006
- Atypia and Ki-67 Expression from Ductal Lavage in Women at Different Risk for Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2006
- Ki-67 Expression in Benign Breast Ductal Cells Obtained by Random Periareolar Fine Needle AspirationCancer Epidemiology, Biomarkers & Prevention, 2005
- The Hallmarks of CancerCell, 2000
- p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breastEuropean Journal of Cancer, 1997
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985